Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Abstract Background: Blonanserin is an atypical antipsychotic that has been marketed in several Asian countries, but the drug-drug interaction (DDI) signals between it and commonly co-prescribed medications have not been systematically evaluated. Objective: This study aimed to systematically explore adverse event (AE) signals for blonanserin both as monotherapy and in combination therapies, using the Japanese Adverse Drug Event Report (JADER) database.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.